Signal generation by glucose
The beta cell is poised to adapt rapidly the rate of insulin secretion to fluctuations in the blood glucose concentration. Glucose equilibrates across the plasma membrane and is phosphorylated by glucokinase, which determines the rate of glycolysis and the generation of pyruvate (see Newgard & McGarry, 1995) . High rates of glycolysis are maintained through the activity of mitochondrial shuttles, mainly the glycerophosphate and malateÏaspartate shuttles (MacDonald, 1981; Eto et al. 1999) , which allow the reoxidation of cytosolic NADH. Other shuttles generating cytosolic NADPH have also been described (MacDonald, 1995; Farfari et al. 2000) . As demonstrated in isolated purified beta cells, as much as 90% of glucose-derived carbons are oxidized by the mitochondria (Schuit et al. 1997) . This is favoured by the very low expression of monocarboxylate transporters in the plasma membrane coupled with low activity of lactate dehydrogenase (Sekine et al. 1994; Ishihara et al. 1999; reviewed in Ishihara & Wollheim, 2000) . Pyruvate, once transported into the mitochondria, is a substrate both for pyruvate dehydrogenase and pyruvate carboxylase. These enzymes ensure, respectively, the formation of acetyl-CoA and oxaloacetate. The latter provides anaplerotic input to the tricarboxylic acid (TCA) cycle (Schuit et al. 1997; Farfari et al. 2000) . Through activation of the TCA cycle, reducing equivalents are transferred to the electron transport chain resulting in hyperpolarisation of the mitochondrial membrane (ÄØm) and generation of ATP. In addition to pyruvate dehydrogenase, two TCA cycle enzymes, isocitrate dehydrogenase and á_ketoglutarate dehydrogenase, are activated by Ca¥ (reviewed by Duchen, 1999) . In the consensus model of glucose-stimulated insulin secretion, mitochondrial metabolism increases the cytosolic ATPÏADP ratio. This leads to closure of ATP-sensitive K¤ channels (KATP) and depolarisation of the plasma membrane. As a Journal of Physiology (2000) Glucose-induced insulin secretion is determined by signals generated in the mitochondria. The elevation of ATP is necessary for the membrane-dependent increase in cytosolic Ca¥, the main trigger of insulin exocytosis. Beta cells depleted of mitochondrial DNA fail to respond to glucose while still secreting insulin in response to membrane depolarisation. This cell model resembles the situation of defective insulin secretion in patients with mitochondrial diabetes. On the other hand, infants with activating mutations in the mitochondrial enzyme glutamate dehydrogenase are characterised by hyperinsulinism and hypoglycaemia. We have recently proposed that glutamate, generated by this enzyme, participates in insulin secretion as a glucose-derived metabolic messenger. In this model, glutamate acts downstream of the mitochondria by sensitising the exocytotic process to Ca¥. The evidence in favour of such a role for glutamate is discussed in the present review.
consequence, the cytosolic Ca¥ concentration ([Ca¥]c) is raised by the opening of voltage-sensitive Ca¥ channels (see Rorsman, 1997) . The increase in [Ca¥] c is the main trigger for exocytosis, the process by which the insulin-containing secretory granules fuse with the plasma membrane (Lang, 1999) . In glucose-stimulated beta cells both the [Ca¥]c rises and the insulin secretion are biphasic with a transient first phase and a second, sustained phase (Bergsten, 1995; Kennedy et al. 1996) . The Ca¥ signal in the cytosol is necessary but not sufficient for the full development of biphasic insulin secretion. It was first shown in 1992 that glucose elicits secretion under conditions of clamped, elevated [Ca¥]c (Gembal et al. 1992; Sato et al. 1992) . The importance of this KATP-independent pathway is illustrated by mouse models lacking functional KATP following the knock-out of either of the two subunits of the channel (Miki et al. 1998; Seghers et al. 2000) . The beta cells of these animals show spontaneous increases in [Ca¥]c and glucose is still able to cause limited insulin secretion. Thus, both the KATP-dependent and -independent insulin secretion require mitochondrial metabolism (Detimary et al. 1994 ).
Mitochondrial diabetes
Non-insulin-dependent diabetes mellitus, or type 2 diabetes, is a polygenic disease characterised by impaired insulin secretion (Porte, 1991) often combined with insulin resistance (Kahn, 1998) . A subform of type 2 diabetes referred to as maternally inherited diabetes and deafness (MIDD) has been linked to mutations in the mitochondrial genome. These mutations involve deletions or point mutations, e.g. in tRNA Leu(UUR) at position 3243 also giving rise to mitochondrial myoencephalopathy, lactic acidosis and stroke-like episodes (MELAS) (Maassen & Kadowaki, 1996) . In MIDD there is a progressive impairment of insulin secretion, which may eventually lead to severe insulin deficiency reminiscent of type 1 (insulin-dependent) diabetes. The clinical picture of these patients illustrates the wellknown dependency of glucose-stimulated insulin secretion on mitochondrial function. It was already demonstrated three decades ago that mitochondrial poisons inhibit the effect of glucose (Hellman, 1970) .
In vitro models of mitochondrial diabetes Patients with mutations in mitochondrial DNA (mtDNA) display heteroplasmy, i.e. mitochondria within the same cells harbour both normal and mutated forms of the multicopy mtDNA. Autopsy of a mitochondrial diabetic with the 3243 mtDNA point mutation revealed much higher heteroplasmy (63%) in beta cells compared with other cell types (Kobayashi et al. 1997) . The mutated mtDNA could be enriched in engineered cell lines by fusing patient-derived enucleated skin fibroblasts with a mtDNA depleted human cell line. After selection, such cybrids carry nearly 100% of either mutated or wild-type mtDNA. These cells with mutated mtDNA exhibited grossly altered morphology of the mitochondria and severely decreased oxygen consumption (van den Ouweland et al. 1999) . Unfortunately, the mitochondria of patient origin cannot be introduced into human beta cells for the study of stimulus-secretion coupling, as human insulin-secreting cell lines are not yet available. By contrast, the mtDNA of several rodent beta cell lines has been depleted by chemical treatment resulting in so-called ñ°cells. In rat insulinoma INS_1 cells mtDNA depletion also resulted in altered mitochondrial morphology and inhibition of glucose-stimulated ATP production ). The latter explains why glucose does not depolarise the plasma membrane potential in INS_1 ñ°c ells (Fig. 1B ) compared with the depolarisation seen in control INS_1 cells (Fig. 1A) . The deficient ATP generation and membrane depolarisation are secondary to the impaired activation of the mitochondrial electron transport chain. This is reflected in the absence of hyperpolarisation of ÄØm normally seen in control cells ( Fig. 1C and D) . Similar results were obtained with the membrane-permeant mitochondrial substrate methyl-succinate ( Fig. 1E -H), which mimics the effect of glucose on insulin secretion (Maechler et al. 1997 ). This suggests that mitochondrial metabolism rather than glycolysis is defective in ñ°cells. As expected from these results, glucose does not increase [Ca¥]c and insulin secretion in different ñ°beta cell line preparations (Soejima et al. 1996; Kennedy et al. 1998; Tsuruzoe et al. 1998; Hayakawa et al. 1998 ). These ñ°cells still synthesise, store and secrete insulin as demonstrated by insulin secretion in response to the [Ca¥]c raising agents KCl and glibenclamide, which do not require mitochondrial metabolism Tsuruzoe et al. 1998; Hayakawa et al. 1998) . Replenishment of MIN_6 ñ°cells with normal mitochondria from mouse fibroblasts completely restored glucose-stimulated insulin secretion as shown in an elegant study by Soejima et al. (1996) . Taken together, these results emphasise the crucial role of the mitochondria in the generation of metabolic coupling factors in glucose-induced insulin release.
Mitochondrially driven insulin exocytosis
Numerous studies have sought to identify the factor(s) mediating the KATP-independent effect of glucose on insulin secretion. Neither protein kinase A nor protein kinase C appeared to be implicated. Malonyl-CoA has been proposed as a metabolic coupling factor in insulin secretion (Prentki et al. 1992) , being a messenger derived from citrate generated in the mitochondria (Farfari et al. 2000 (Denton & McCormack, 1980; Hansford, 1985) , including insulin-secreting cells (Sener et al. 1990; Civelek et al. 1996; Maechler et al. 1998) . Therefore, the increase in [Ca¥]m conveniently reflects mitochondrial activation (Rizzuto et al. 1992; Duchen, 1999 Fig. 2A) , an effect secondary to hyperpolarisation of ÄØm (Maechler et al. 1997 ). This mitochondrial activation resulted in biphasic insulin release (Fig. 2B) . As Ca¥ enhances succinate oxidation under these conditions these conditions (Maechler et al. 1997 ). This strongly suggested the existence of a mitochondrial factor generated through anaplerotic input into the TCA cycle.
Is glutamate the mitochondrially derived coupling factor?
Using the á_toxin-permeabilised cell model, metabolic intermediates of mitochondrial origin were screened for their putative direct action on insulin exocytosis. These and other experiments suggested glutamate as the coupling factor. Glucose increased the cellular glutamate content in INS_1 cells and human islets glutamate (Danielsson et al. 1970 ). Thus, conflicting data emanate from different laboratories regarding the effect of glucose on glutamate levels. This discrepancy might be explained by culture conditions that can substantially increase the background of glutamate, especially in the case of whole islets constituted of a mixture of beta and non-beta cells (Michalik et al. 1992) . Basal total glutamate levels range from sub-millimolar in INS_1 cells to millimolar in the islet preparations (Danielsson et al. 1970; Michalik et al. 1992; MacDonald & Fahien, 2000) . These data obtained in whole cells do not yield information on changes in the cytosol, the critical compartment for a putative messenger molecule, since mitochondria and possibly secretory granules contain glutamate. In isolated INS_1 cell mitochondria, succinate generates glutamate under conditions in which insulin secretion is stimulated in permeabilised cells (Maechler et al. 2000) . Using a mannitol-sucrose buffer, unfortunately without a set Ca¥ concentration, MacDonald & Fahien (2000) did not observe this effect of succinate in rat islet mitochondria.
Irrespective of the glutamate levels measured in glucosestimulated cells, the principal observation is that glutamate directly stimulates insulin exocytosis in permeabilised cells at permissive [Ca¥] c independently of mitochondrial activation . This was corroborated by addition to permeabilised cells of oligomycin, an inhibitor of the mitochondrial ATP synthase. Oligomycin abolished insulin release in response to succinate without affecting glutamate-induced exocytosis ( Fig. 3A and B) . These results suggest that glutamate, in contrast to succinate, acts downstream of mitochondrial metabolism. Finally, addition of the cell-permeant derivative diemethyl-glutamate to intact beta cell preparations only stimulates insulin secretion at intermediate but not at basal or optimal glucose concentrations (Sener et al. 1994; . Similarly, glutamine, which forms glutamate in the beta cell (Michalik et al. 1992) , enhances insulin release only in the presence of other nutrient stimuli . The converging evidence favours the contention that intracellular glutamate requires other glucose-triggered signals, such as an increase in [Ca¥]c.
Role of glutamate in beta cell function
We thus postulate an intracellular messenger role for glutamate in stimulus-secretion coupling. Previously, extracellular glutamate was reported to cause a transient stimulation of insulin secretion in the perfused rat pancreas (Bertrand et al. 1992) and to elicit a small secretory response in isolated rat islets (Inagaki et al. 1995) . It is noteworthy that only approximately 25% of rat beta cells express glutamate receptors (Weaver et al. 1996) and that glutamate does not elicit insulin release in intact rat islets (Fahien et al. 1988) or INS_1 cells (authors' unpublished observations). We therefore suggest that glutamate acts as an intracellular rather than an extracellular messenger in insulin exocytosis. Glutamate can be generated through several biochemical pathways including transamination reactions (see Nissim, 1999) . Predominantly, in the mitochondria, glutamate dehydrogenase forms glutamate from the TCA cycle intermediate á_ketoglutarate (Fig. 4) . In most tissues this is the prevailing direction for the enzyme reaction with the notable exception of astrocytes (reviewed by Hudson & Daniel, 1993; Nissim, 1999) . Several studies have addressed the question of the importance of glutamate dehydrogenase in the pancreatic beta cell. It is noteworthy that glutamine oxidation, stimulated by the presence of an allosteric activator of glutamate dehydrogenase, is inhibited by glucose (Gao et al. 1999) . The most likely donors of ammonia for glutamate synthesis by glutamate dehydrogenase are glutamine and aspartate (Nissim, 1999) . In the cerebral cortex glutamate production from glucose has been shown to reflect TCA cycle activity and carbon flux in resting humans and exercising rats (Hyder et al. 1996; Shen et al. 1999) . The directional flux was also increased in mouse islets since incorporation of glucose carbons into glutamate was augmented by glucose stimulation without a change in cellular glutamate content (Gylfe & Hellman, 1974) . The glutamate formed in the mitochondria is transferred to the cytosol where it is probably taken up by the insulincontaining granules (Fig. 4) . In agreement with glutamate transport properties in synaptic vesicles (see Ozkan & Ueda, 1998) , collapse of the granule membrane potential and application of an inhibitor of glutamate uptake blocked glutamate-induced insulin exocytosis in permeabilised INS_1 cells . However, glutamate uptake by insulin-containing secretory granules remains to be demonstrated. Glutamate may be transported by the recently identified vesicular glutamate transporter VGLUT1 or BNPI (Bellocchio et al. 2000; Takamori et al. 2000) . It can be speculated that glutamate has a general effect of sensitising secretory vesicles to the action of Ca¥ in exocytosis. Interestingly, glutamate is usually used as the main anion in experiments employing permeabilised cells or the patch-clamp technique for the monitoring of exocytosis. Churcher & Gomperts (1990) used Cl¦ as the main anion in permeabilised mast cells and in fact observed that glutamate was required for Ca¥-induced exocytosis. Our experiments, like those in the mast cells, employed a buffer containing Cl¦ as the main anion . At present, the mechanism underlying the permissive action of glutamate in the secretory process is unknown.
Conclusion
Glutamate may not only play a role in the physiological regulation of insulin secretion but may also be implicated in beta cell pathology. It is of interest in this context that a syndrome of hyperinsulinism has been linked to mutations in the glutamate dehydrogenase gene resulting in an increase in enzyme activity (Stanley et al. 1998; Yorifuji et al. 1999 ).
The impact of these mutations on insulin secretion has its counterpart in the allosteric stimulation of the enzyme by the amino acid analogue 2-amino-bicyclo[2,2,1]heptane-2-carboxylic acid . The putative role of glutamate as a messenger has recently been substantiated in a transgenic mouse model. Those mice overexpressing the glutamate decarboxylating enzyme GAD65 display glucose intolerance without any sign of insulitis or loss of beta cells. Their islets showed impaired glucose-stimulated insulin secretion, while the response to KCl was preserved (Shi et al. 2000) .
In conclusion, although the crucial role of the mitochondria in beta cell function is well recognised, the last decade has revealed that metabolism-secretion coupling is more complex than originally expected. It may be speculated that not only ATP and glutamate but also other mitochondrially derived factors participate in the overall control of exocytosis. The elucidation of the mode of glutamate action in the beta cell should help to define its putative implication in other secretory processes. 
